Trials / Sponsors / Shanxi Kangbao Biological Product Co., Ltd.
Shanxi Kangbao Biological Product Co., Ltd.
Industry · 6 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Exploratory Study of LP-98 for Injection in ART-Naive HIV-Infected Individuals HIV | Phase 1 / Phase 2 | 2026-01-29 |
| Completed | Pharmacokinetics and Efficacy of Multiple Dosing of LP-98 for Injection in HIV-infected Patients Hiv | Phase 1 / Phase 2 | 2024-09-02 |
| Completed | Assess the Effectiveness and Safety of Lipovirtide Combined With Nucleoside Drugs in HIV-infected Patients. HIV | Phase 2 | 2023-11-02 |
| Completed | Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of LP-98 Injection in Healthy Hiv | Phase 1 | 2023-07-13 |
| Completed | Pharmacokinetics and Efficacy of Multiple Dosing of Lipovirtide for Injection in HIV-infected Patients HIV Infections | Phase 1 | 2022-06-10 |
| Completed | A Study to Assess the Safety, Tolerability and Pharmacokinetics of Lipovirtide in HIV-infected Patients HIV Infections | Phase 1 | 2021-01-23 |